Mark Identification

ANSUVIMAB

Serial Number

88921860

Filing Date

May 18, 2020

Trademark by

Classification Information

Human antibody-based pharmaceutical for treatment and prophylaxis for Ebola Virus Disease

Treatment and prophylaxis for Ebola Virus Disease using human antibodies